A Breakthrough in Long COVID: How a Common Antidepressant Is Offering New Hope for Fatigue
For millions of people worldwide, the end of an acute COVID-19 infection was not the end of their health struggles....
For millions of people worldwide, the end of an acute COVID-19 infection was not the end of their health struggles....
For decades, the weight-loss industry has been plagued by the "yo-yo effect"—a cycle of rapid initial weight loss followed by...
For decades, the public health narrative has centered on the dangers of refined sugar, leading millions to embrace low- and...
As the legal landscape for marijuana shifts across the globe, a pervasive cultural narrative has taken root: the assumption that...
In a landmark development for nephrology, a major international clinical trial has revealed that the drug finerenone can significantly slow...
Glioblastoma multiforme (GBM) has long stood as one of the most formidable adversaries in oncology. As the most aggressive form...
In the relentless global pursuit of a viable treatment for Alzheimer’s disease, researchers at King’s College London (KCL) have unveiled...
For decades, the food industry has marketed low-calorie and artificial sweeteners as "biologically inert" shortcuts—substances that provide the sensory reward...
For most of human evolutionary history, the human gut was a bustling, crowded ecosystem. We were not merely hosts to...
For millions of people living with depression, the road to recovery is often uneven. While modern antidepressants and therapeutic interventions...